PERRY MICHAEL S
- SEC CIK
- 0001250379
Latest role at each company
- ARWR ARROWHEAD PHARMACEUTICALS, INC.Directoras of Aug 20, 2026
- RCEL AVITA Medical, Inc.Directoras of Nov 22, 2022
Trades
Every Form 4 that lists PERRY MICHAEL S as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| ARWRARROWHEAD PHARMACEUTICALS, INC. | Aug 20, 20265:22 PM ET | Aug 18, 2026 | PERRY MICHAEL SDirector | SSaleCommon Stock | −11.6K | $87.30 | −$1.01M | 111.46K | −9.4% | SEC |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | Dec 9, 2025 | Dec 5, 2025 | PERRY MICHAEL SDirector | SSaleCommon Stock | −16.25K | $61.03 | −$991.74K | 115.24K | −12.4% | SEC |
| RCELAVITA Medical, Inc. | Nov 22, 2022 | Nov 21, 2022 | PERRY MICHAEL SDirector | SSaleCommon Stock | −150K | $7.18 | −$1.08M | 229.54K | −39.5% | SEC |
| RCELAVITA Medical, Inc. | Feb 25, 2022 | Feb 24, 2022 | PERRY MICHAEL SChief Executive Officer | SSaleCommon Stock | −10.81K | $8.74 | −$94.5K | 321.71K | −3.3% | SEC |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | Jan 4, 2022 | Jan 3, 2022 | PERRY MICHAEL SDirector | SSaleCommon Stock | −4.5K | $64.7094 | −$291.19K | 85.5K | −5.0% | SEC |
| RCELAVITA Medical, Inc. | Sep 7, 2021 | Sep 1, 2021 | PERRY MICHAEL SChief Executive Officer | SSaleCommon Stock | −11.22K | $20.68 | −$232.03K | 237.64K | −4.5% | SEC |